Interestingly, combination of anti-CTLA-4 and antiPD-L1 in HCC patients resulted in an increase of proliferating CD8 T-cells [37], suggesting that addition of a vaccine may promote even a higher proliferative burst, as observed in our results. This evidence concerns the gene CTLA4 and hepatocellular carcinoma.